Status | Study |
Not yet recruiting |
Study Name: Efficacy and Tolerability of Grazoprevir and Elbasvir in Peginterferon Alfa Plus Ribavirin Experienced Patients With Chronic Genotype 1 HCV and HIV Co-infection: a Non-randomised, Open-label Clinical Trial Condition: To Assess the Efficacy of Grazoprevir 100mg and Elbasvir 50mg by Determining the Proportion of Sustained Virological Response 12 Weeks After the End of Therapy Date: 2017-03-27 Interventions: Drug: grazoprevir and elbasvir For patients with chronic genotype 1a, with or without resistance associa |
Not yet recruiting |
Study Name: Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B Condition: HCV Coinfection Date: 2016-12-11 Interventions: Drug: VEKIRAX |
Terminated |
Study Name: Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT) Condition: HIV/HCV Coinfection Date: 2016-05-03 Interventions: Drug: Peginterferon Alfa-2 Peginterferon alfa-2a will be administered as 90 micrograms (mcg) via subcuta |
Recruiting |
Study Name: Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir Condition: Hepatitis C and HIV Coinfection Date: 2015-10-26 Interventions: Other: Blood draws for tenofovir PK, renal function |
Recruiting |
Study Name: DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) Condition: Chronic Hepatitis C Infection HBV Coinfection Date: 2015-09-20 Interventions: Drug: Ledipasvir/Sofosbuvir Or |
Completed |
Study Name: Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection Condition: Hepatitis C Infection With HIV Co-Infection Date: 2015-05-27 Interventions: Drug: LDV/SOF 90/400 mg FDC tablet administered orally once daily |
Completed |
Study Name: A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection Condition: HBV/HCV Co-infection Date: 2015-01-12 Interventions: Other: Abbreviation of treatment duration |
Completed |
Study Name: Effects of Viral and Bacterial Co-infections in Otherwise Healthy Children Hospitalized in Pediatric Department Condition: Coinfection Date: 2014-12-02 Interventions: Other: No intervention As this is an observational study, no intervention was conducted. |
Completed |
Study Name: Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection Condition: HIV Hepatitis C Co-Infection Date: 2014-11-17 Interventions: Behavioral: Prep-C PREP-C is a |
Completed |
Study Name: Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection Condition: Viral Hepatitis C HIV Date: 2014-04-24 Interventions: Drug: Sofosbuvir/Ledipasvir fixed dose SOF 400 mg/LDV 90 mg FDC tablet administered orally once daily |